Pegfilgrastim (Pegstim) is supplied as a single dose pre-filled syringe of 0.6 mL for subcutaneous administration only. Each prefilled syringe of 0.6 mL contains 6 mg Pegfilgrastim.
For the treatment of chemotherapy-induced neutropenia, the recommended adult dosage of Pegfilgrastim (Pegstim) is a single 6 mg injection administered subcutaneously once per chemotherapy cycle. Dosage of Pegfilgrastim (Pegstim) does not need to be modified based on body weight. Pegfilgrastim (Pegstim) should not be administered during the 14 days before or 24 hours after administration of cytotoxic chemotherapy.
Special Populations: No special population dosage recommendations at this time.
Other Services
Country
Account